InConversation: HMi meets Pablo Cironi, Director of Life Science Investment Funds at Caixa Capital Risc

In November 2021, Switzerland-based Vifor Pharma, a global pharmaceuticals company focused on iron deficiency, nephrology and cardio-renal therapies, entered an agreement to acquire Spain-based Sanifit Therapeutics, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders. The transaction represented both the largest acquisition seen in the Spanish biotechnology sector and the biggest…